Copeptin level after carotid endarterectomy and perioperative stroke

Angiology

Volumn 65, Issue 2, 2014, Pages 122-129

  Maravic Stojkovic, Vera ^a   Lausevic Vuk, L J ^a   Obradovic, M ^b   Jovanovic, P ^a   Tanaskovic, S ^a   Stojkovic, B ^a   Isenovic, R E ^b   Radak, D J ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

acute stroke; biomarkers; C reactive protein; carotid endarterectomy; copeptin; interleukin 6

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; INTERLEUKIN 6;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HORMONE DETERMINATION; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; STRESS;

EID: 84891888692     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712473637     Document Type: Article

References (56)

1. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med. 1998 ; 339 (20). 1415-1425
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). Lancet. 1998 ; 351 (9113). 1379-1387
3. Swain S, Turner C, Tyrrell P, Rudd A.. Diagnosis and initial management of acute stroke and transient ischemic attack: summary of NICE guidance. BMJ. 2008 ; 337 (24). a786
4. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ. Guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. J Neurointerv Surg. 2011 ; 3 (2). 100-130
5. Liapis CD, Bell PR, Mikhailidis D, et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg.. 2009 ; 37 (suppl 4). 1-19
6. Courbier R, Ferdani M Reoperative Arterial Surgery. Bergan JJ Yao JST, ed. Orlando, FL: Grune & Stratton ; 1986: 495-509.
7. Imparato AM, Riles TS, Lamparello PJ, Ramirez AA Complications in Vascular Surgery. 2 nd ed. Orlando, FL: Grune & Stratton; 1985:725-738. Bernhard VM Towne JB, ed. Orlando, FL: Grune & Stratton ; 1985: 725-738.
8. Jernigan WR, Fulton RL, Hamman JL, Miller FB, Mani SS. The efficacy of routine completion operative angiography in reducing the incidence of perioperative stroke associated with carotid endarterectomy. Surgery. 1984 ; 96 (5). 831-836
9. Rosenthal D, Zeichner WD, Lamis PA, Stanton PE. Neurologic deficit after carotid endarterectomy: pathogenesis and management. Surgery. 1983 ; 94 (5). 776-780
10. Treiman RC, Cossman DV, Cohen JL, Foran RF, Levin PM. Management of postoperative stroke after carotid endarterectomy. Am J Surg. 1981 ; 142 (2). 236-238
11. Ye JR, Myers KA, Scott DF, Devine TJ, Flanc C. Perioperative stroke after carotid endarterectomy: etiological risk factors and management. Chin Med J (Engl). 1994 ; 107 (6). 460-463
12. Blaisdel FW. Routine operative arteriography following carotid endarterectomy. Surgery. 1978 ; 83 (1). 114-115
13. Cuming R, Blair SD, Powell JT, Greenhalgh RM. The use of duplex scanning to diagnose perioperative carotid occlusions. Eur J Vasc Surg. 1994 ; 8 (2). 143-147
14. Earnshaw JJ. Carotid endarterectomy-the evidence. J Royal Soc Med. 2002 ; 95 (4). 168-170
15. Katan M, Elkind M. Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Rev Neurother. 2011 ; 11 (2). 225-239
16. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med. 2006 ; 166 (19). 2073-2080
17. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005 ; 5 (8). 629-640
18. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM.. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004 ; 4 (15). 2-10
19. Murakami Y, Saito K, Hara A, et al. Increases in tumour necrosis factor-α following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J Neurochem. 2005 ; 93 (6). 1616-1622
20. Katan M, Fluri F, Morgenthaler NG, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol. 2009 ; 66 (6). 799-808
21. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Failure. 2010 ; 16: S37 - S44
22. Marques JS, Almeida AG, David C, Luz-Rodrigues H, Diogo NS.. Copeptin for discriminating two-year mortality in heart failure patients with moderate to severe systolic dysfunction. J Clin Exp Cardiol. 2012 ;: S - 2
23. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. JACC. 2010 ; 55 (19). 2096-2106
24. Morgenthaler NG, Struck J, Jochenberger S, Dunser M. Copeptin: clinical use of a new biomarker. Trend Endocrinol Metab. 2008 ; 19 (2). 43-49
25. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett. 1984 ; 167 (1). 93-97
26. Meisner M. A New, Innovative Infection Parameter. 3 rd ed. Stuttgart, NY: Georg Thieme Verlag; 2000:15-27. Stuttgart, NY: Georg Thieme Verlag ; 2000: 15-27.
27. Jarai R, Mahla E, Perkmann T, et al. Usefulness of pre-operative copeptin concentrations to predict post-operative outcome after major vascular surgery. Am J Cardiol. 2011 ; 108 (8). 1188-1195
28. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003 ; 107 (3). 499-511
29. Lees CD, Hertzer NR. Postoperative stroke and late neurological complications after carotid endarterectomy. Arch Surg. 1981 ; 116 (12). 1561-1568
30. Riles TS Current Critical Problems in Vascular Surgery. Veith FJ, ed. St. Louis, MO: Quality Medical Publishing ; 1991: 412-415.
31. Whiteley W, Wardlaw J, Dennis M, et al. The use of blood markers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke. 2012 ; 43 (1). 86-891
32. De Marchis GM, Katan M, Weck A, et al. Validation of copeptin as prognostic marker in ischemic stroke. Clin Neurophysiol. 2010 ; 29 (3). 259-264
33. Katan M, Nigro N, Fluri F, et al. Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology. 2011 ; 76 (6). 563-566
34. Gogenhuber A, Struck J, Dieplinger B, et al. Comparative evaluation of B-type natriuretic peptide, mid regional pro-A-type natriuretic peptide, mid regional pro-adrenomedulin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail. 2007 ; 13 (1). 42-49
35. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995 ; 332 (20). 1351-1363
36. Whiteley W, Jackson C, Lewis S, et al. Association of circulating inflammatory markers with recurrent vascular events after stroke. Stroke. 2011 ; 42 (1). 10-16
37. Kageyama K, Tamasawa N, Suda T. Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications. Stress. 2011 ; 14 (4). 357-367
38. Snyers L, De Wit L, Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A. 1990 ; 87 (7). 2838-2842
39. Berczi I, Quaintanar-Stephano A, Kovacs K. Neuroimmune regulation in immunocompetence, acute illness, and healing. Ann N Y Acad Sci. 2009 ; 1153: 220-239
40. Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin-6. Immunol Today. 1990 ; 11 (12). 443-449
41. Ganter U, Arcone R, Toniatti C, Morrone G, Cilberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 1989 ; 8 (12). 3773-3779
42. Elkind MSV, Leon V, Moon YP, Sacco RL. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction. Stroke. 2009 ; 40 (10). 3233-3237
43. Paraskevas KI, Mikhailidis DP, Veith FJ. Optimal statin type and dosage for vascular patients. J Vasc Surg. 2011 ; 53 (3). 837-844
44. Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Statins and noncardiac vascular disease. Curr Opin Cardiol. 2012 ; 27 (4). 392-397
45. Liapis CD, Bell PF, Mikhailidis DP, et al. ESVS guidelines collaborators European Society for Vascular Surgery; ESVS guidelines: section A - prevention in patients with carotid stenosis. Curr Vasc Pharmacol. 2010 ; 8 (5). 673-681
46. Paraskevas KI, Veith FJ, Liapis CD, Mikhailidis DP. Perioperative/ periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update [published online January 20]. Curr Vasc Pharmacol. 2012 ;:
47. Metso TM, Metso AJ, Helenius J, et al. Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke. 2007 ; 38 (6). 1837-1842
48. Engelter ST, Brandt T, Debette S, et al. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke. 2007 ; 38 (9). 2605-2611
49. Menon R, Kerry S, Norris JW, Markus HS. Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2008 ; 79 (10). 1122-1127
50. Georgiadis D, Arnold M, von Buedingen HC, et al. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology. 2009 ; 72 (21). 1810-1815
51. Elkind MSV. Princeton proceedings: inflammatory mechanisms of stroke. Stroke. 2010 ; 41 (10). S3 - S8
52. Maravic-Stojkovic V, Lausevic-Vuk Lj, Jovic M, et al. Procalcitonin-based therapeutic strategy to reduce antibiotic use on patients after cardiac surgery. Srp Arch Celok Lek. 2011 ; 139 (11-12). 736-742
53. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that stratified diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011 ; 17 (6). 764-769
54. Kageyama K, Hanada K, Iwasaki Y, et al. Pituitary adenylate cyclase-activating polypeptide stimulates corticotrophin-releasing-factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol. 2007 ; 195 (2). 199-211
55. Nakou ES, Elisaf MS, Liberopulos EN. High-sensitivity C-reactive protein: to measure or not to measure?. Open Clin Chem. J.. 2010 ; 3: 10-18
56. Radak D, Tanasković S, Matić P, Babić S, Aleksić N, Ilijevski N. Eversion carotid endarterectomy-our experience after 20 years of carotid surgery and 9897 carotid endarterectomy procedures. Ann Vasc Surg. 2012 ; 26 (7). 924-928